Astrazeneca Pharma India Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Jun'26

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Jun 2026 is 18.01% vs -5.39% in Mar 2026

Standalone Net Profit

QoQ Growth in quarter ended Jun 2026 is -15.49% vs 37.71% in Mar 2026

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is -19.65% vs 35.87% in Mar 2026

Interest

QoQ Growth in quarter ended Jun 2026 is -4.41% vs 92.45% in Mar 2026

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

Compare Quarterly Results Of Astrazeneca Phar With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

682.79

778.88

-96.09

-12.34%

Other Operating Income

0.00

22.99

-22.99

-100.00%

Total Operating income

682.79

801.87

-119.08

-14.85%

Raw Material Cost

0.00

377.12

-377.12

-100.00%

Purchase of Finished goods

304.62

0.00

304.62

(Increase) / Decrease In Stocks

142.59

-23.37

165.96

710.14%

Employee Cost

79.16

113.18

-34.02

-30.06%

Power Cost

0.00

Manufacturing Expenses

0.00

0.01

-0.01

-100.00%

Selling and Distribution Expenses

30.75

0.00

30.75

Other Expenses

76.73

203.48

-126.75

-62.29%

Total Expenditure (Excl Depreciation)

633.85

670.42

-36.57

-5.45%

Operating Profit (PBDIT) excl Other Income

48.94

131.45

-82.51

-62.77%

Other Income

9.23

13.78

-4.55

-33.02%

Operating Profit (PBDIT)

58.17

145.23

-87.06

-59.95%

Interest

1.95

9.61

-7.66

-79.71%

Exceptional Items

-0.24

0.00

-0.24

Gross Profit (PBDT)

55.98

135.62

-79.64

-58.72%

Depreciation

5.23

39.06

-33.83

-86.61%

Profit Before Tax

50.75

96.56

-45.81

-47.44%

Tax

12.82

24.82

-12.00

-48.35%

Provisions and contingencies

0.00

Profit After Tax

37.93

71.75

-33.82

-47.14%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

37.93

71.75

-33.82

-47.14%

Equity Capital

5.00

24.78

-19.78

-79.82%

Face Value

2.00

1.00

0.00

Reserves

0.00

Earnings per share (EPS)

15.17

2.90

12.27

423.10%

Diluted Earnings per share

15.17

2.84

12.33

434.15%

Operating Profit Margin (Excl OI)

7.17%

16.88%

0.00

-9.71%

Gross Profit Margin

8.20%

17.41%

0.00

-9.21%

PAT Margin

5.56%

9.21%

0.00

-3.65%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 682.79 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 18.01% vs -5.39% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 29.73% vs 35.81% in Jun 2025

Quarterly - Standalone Net Profit

Standalone Net Profit 37.93 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is -15.49% vs 37.71% in Mar 2026

YoY Growth in quarter ended Jun 2026 is -32.06% vs 573.54% in Jun 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 48.94 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is -19.65% vs 35.87% in Mar 2026

YoY Growth in quarter ended Jun 2026 is -39.66% vs 113.05% in Jun 2025

Quarterly - Interest

Interest 1.95 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is -4.41% vs 92.45% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 170.83% vs 554.55% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 7.17%

in Jun 2026

Figures in %

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025